AKT1 and urinary bladder cancer: The PI3K/AKT pathway is activated by TGF-β [70,71,72,73], and this signaling pathway has also been demonstrated to enhance bone metastasis of prostate cancer [74], renal cell carcinoma [75], and bladder cancer [76].